Safety and Tolerability of Cyclophosphamide Versus Mycophenolate for Systemic Sclerosis-Related Interstitial Lung Disease

被引：0

作者：

Volkmann, Elizabeth R. ^{[1
]}

Roth, Michael ^{[1
]}

Elashoff, Robert ^{[2
]}

Clements, Philip J. ^{[1
]}

Furst, Daniel E. ^{[1
]}

Khanna, Dinesh ^{[3
]}

Goldin, Jonathan ^{[4
]}

Tashkin, Donald ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Med, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Biomath, Los Angeles, CA 90095 USA

[3] Univ Michigan, Med, Ann Arbor, MI 48109 USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1076

引用

页数：2

共 50 条

[21] Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease [J].

Robert L. Mango ;

Eric L. Matteson ;

Cynthia S. Crowson ;

Jay H. Ryu ;

Ashima Makol .

Lung, 2018, 196 :409-416

[22] Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease [J].

Kim, Grace Hyun J. ;

Tashkin, Donald P. ;

Lo, Pechin ;

Brown, Matthew S. ;

Volkmann, Elizabeth R. ;

Gjertson, David W. ;

Khanna, Dinesh ;

Elashoff, Robert M. ;

Tseng, Chi-Hong ;

Roth, Michael D. ;

Goldin, Jonathan G. .

ARTHRITIS & RHEUMATOLOGY, 2020, 72 (02) :316-325

[23] Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease [J].

Khanna, Dinesh ;

Albera, Carlo ;

Fischer, Aryeh ;

Seibold, James R. ;

Khalidi, Nader A. ;

Raghu, Ganesh ;

Chung, Lorinda ;

Schiopu, Elena ;

Chen, Dan ;

Gorina, Eduard .

ARTHRITIS & RHEUMATOLOGY, 2015, 67

[24] Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial [J].

Acharya, Nupoor ;

Sharma, Shefali Khanna ;

Mishra, Debashish ;

Dhooria, Sahajal ;

Dhir, Varun ;

Jain, Sanjay .

RHEUMATOLOGY INTERNATIONAL, 2020, 40 (05) :703-710

[25] DEVELOPMENT OF A COMPOSITE OUTCOME MEASURE FOR SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE [J].

Volkmann, E. ;

Li, N. ;

Tashkin, D. ;

Furst, D. ;

Elashoff, R. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) :S28-S28

[26] Distinct Immune Cell Subsets in Systemic Sclerosis-related Interstitial Lung Disease [J].

Saligrama, Phan ;

Wilfong, Erin ;

Rizzi, Elise ;

Crofford, Leslie ;

Kendall, Peggy .

ARTHRITIS & RHEUMATOLOGY, 2022, 74 :2306-2307

[27] DEVELOPMENT OF A COMPOSITE OUTCOME MEASURE FOR SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE [J].

Volkmann, E. ;

Li, N. ;

Tashkin, D. ;

Furst, D. ;

Elashoff, R. .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 :165-165

[28] Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease [J].

Neslihan Yilmaz ;

Yasin Abul ;

Muge Bicakcigil ;

Pejman Golabi ;

Cigdem Celikel ;

Sait Karakurt ;

Sule Yavuz .

Rheumatology International, 2012, 32 :1921-1925

[29] Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease [J].

Yilmaz, Neslihan ;

Abul, Yasin ;

Bicakcigil, Muge ;

Golabi, Pejman ;

Celikel, Cigdem ;

Karakurt, Sait ;

Yavuz, Sule .

RHEUMATOLOGY INTERNATIONAL, 2012, 32 (07) :1921-1925

[30] Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease [J].

Assassi, Shervin ;

Volkmann, Elizabeth R. ;

Zheng, W. Jim ;

Wang, Xuan ;

Wilhalme, Holly ;

Lyons, Marka A. ;

Roth, Michael D. ;

Tashkin, Donald P. .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (06) :854-860

← 1 2 3 4 5 →